DexCom, Inc. Profile Avatar - Palmy Investing

DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, a…
Medical - Devices
US, San Diego [HQ]
DXCM/Financial Reporting

Income Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
29.00 48.00 76.00 99.00 160.00 259.00 402.00 573.00 718.00 1,031.00 1,476.00 1,926.00 2,448.00 2,909.00 3,622.00
EPS
-0.30 -0.24 -0.17 -0.20 -0.10 -0.07 -0.18 -0.20 -0.15 -0.36 0.28 1.31 0.40 0.88 1.40
Profit
3.00 18.00 35.00 46.00 100.00 176.00 278.00 378.00 492.00 663.00 931.00 1,280.00 1,680.00 1,883.00 2,288.00
Pre Tax
-53.00 -55.00 -44.00 -55.00 -29.00 -22.00 -57.00 -64.00 -48.00 -126.00 104.00 225.00 173.00 390.00 710.00
ETR
- - -17.91 0.22 2.33 - - -0.45 -0.17 -1.08 -3.29 -0.47 2.98 -119.38 11.04 12.69 23.78
Net
-53.00 -55.00 -44.00 -54.00 -29.00 -22.00 -57.00 -65.00 -50.00 -127.00 101.00 493.00 154.00 341.00 541.00
EBITDA
-43.00 -34.00 -41.00 -49.00 -21.00 -21.00 -57.00 -64.00 -35.00 -103.00 164.00 382.00 277.00 416.00 916.00
Operating Income
-45.00 -45.00 -44.00 -55.00 -28.00 -21.00 -57.00 -63.00 -42.00 -186.00 142.00 299.00 175.00 391.00 597.00
Interest Income
- - - - - - - - - - - - - - - - 3.00 2.00 26.00 16.00 1.00 18.00 135.00
Loss
-75.00 -93.00 -121.00 -155.00 -188.00 -280.00 -459.00 -637.00 -761.00 -1,217.00 -1,333.00 -1,627.00 -2,182.00 -2,518.00 -3,024.00
Cost of Revenue
-26.00 -30.00 -40.00 -53.00 -59.00 -82.00 -123.00 -194.00 -226.00 -367.00 -544.00 -646.00 -768.00 -1,026.00 -1,333.00
Operating Expenses
-49.00 -63.00 -80.00 -102.00 -129.00 -197.00 -335.00 -442.00 -534.00 -850.00 -789.00 -980.00 -1,414.00 -1,491.00 -1,691.00
Depreciation and Amortization
-2.00 -2.00 -3.00 -6.00 -7.00 -8.00 -10.00 -15.00 -16.00 -29.00 -48.00 -67.00 -102.00 -155.00 -186.00
Interest Expenses
-8.00 -1.00 - - - - - - - - - - - - -12.00 -22.00 -60.00 -84.00 -102.00 -18.00 -20.00
Other Expenses
-7.00 -8.00 - - - - - - - - - - - - -3.00 -80.00 -38.00 -74.00 -1.00 - - -2.00
WA Shares Outstanding
177.00 227.00 262.00 274.00 284.00 300.00 319.00 334.00 345.00 352.00 364.00 377.00 386.00 389.00 386.00
End of DXCM's Analysis
CIK: 1093557 CUSIP: 252131107 ISIN: US2521311074 LEI: - UEI: -
Secondary Listings
DXCM has no secondary listings inside our databases.